Licochalcone E reduces chronic allergic contact dermatitis and inhibits IL-12p40 production through down-regulation of NF-κB

International Immunopharmacology

Volumn 10, Issue 9, 2010, Pages 1119-1126

  Cho, Young Chang ^a   Lee, Sung Ho ^a   Yoon, Goo ^b   Kim, Hyung Seok ^a,c   Na, Joo Young ^a,c   Choi, Hyun Jin ^a   Cho, Cheng Weon ^d   Cheon, Seung Hoon ^a   Kang, Bok Yun ^a  

^a Chonnam National University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c Chonnam National University Medical School   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

Allergic contact dermatitis; Inteleukin 12p40; Licochalcone E; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; LICOCHALCONE A; LICOCHALCONE E; LIPOPOLYSACCHARIDE; OXAZOLONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTACT DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DOWN REGULATION; DRUG ACTIVITY; DRUG DOSE COMPARISON; FEMALE; GENE MAPPING; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SKIN INFLAMMATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CHALCONES; CHRONIC DISEASE; DERMATITIS, ALLERGIC CONTACT; DOWN-REGULATION; FEMALE; INTERLEUKIN-12 SUBUNIT P40; MACROPHAGES; MICE; MICE, INBRED C57BL; NF-KAPPA B; OXAZOLONE; PROMOTER REGIONS, GENETIC;

EID: 77955920339     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.06.015     Document Type: Article

References (46)

1. Brod S.A., Benjamin D., Hafler D.A. Restricted T cell expression of IL-2/IFN-gamma mRNA in human inflammatory disease. J Immunol 1991, 147:810-815.
2. Morelli A.E., O'Connell P.J., Khanna A., Logar A.J., Lu L., Thomson A.W. Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection. Transplantation 2000, 69:2647-2657.
3. Hill J.A., Polgar K., Anderson D.J. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995, 273:1933-1936.
4. Parronchi P., Romagnani P., Annunziato F., Sampognaro S., Becchio A., Giannarini L., et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997, 150:823-832.
5. Trinchieri G., Pflanz S., Kastelein R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003, 19:641-644.
6. Hunter C.A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005, 5:521-531.
7. Hibbert L., Pflanz S., De Waal Malefyt R., Kastelein R.A. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 2003, 23:513-522.
8. Lucas S., Ghilardi N., Li J., de Sauvage F.J. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci USA 2003, 100:15047-15052.
9. Lankford C.S., Frucht D.M. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 2003, 73:49-56.
10. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715-725.
11. Sieburth D., Jabs E.W., Warrington J.A., Li X., Lasota J., LaForgia S., et al. Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5. Genomics 1992, 14:59-62.
12. Lupardus P.J., Garcia K.C. The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with interleukin-12. J Mol Biol 2008, 382:931-941.
13. Presky D.H., Yang H., Minetti L.J., Chua A.O., Nabavi N., Wu C.Y., et al. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci USA 1996, 93:14002-14007.
14. Parham C., Chirica M., Timans J., Vaisberg E., Travis M., Cheung J., et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002, 168:5699-5708.
15. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004, 202:139-156.
16. Bacon C.M., Petricoin E.F., Ortaldo J.R., Rees R.C., Larner A.C., Johnston J.A., et al. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci USA 1995, 92:7307-7311.
17. Shakhov A.N., Lefgen H., Drutskaya L.N., Kuprash D.V., Nedospasov S.A. Transcriptional regulation of the gene, encoding p40 subunit of IL-12 and IL-23, in murine macrophages. Russ J Immunol 2001, 6:357-366.
18. Kajiyama K., Demizu S., Hiraga Y., Kaoru K., Koyama K., Takahashi K., et al. Two prenylated retrochalcones from Glycyrrhiza inflata. Phytochemistry 1992, 31:3229-3232.
19. Yoon G., Jung Y.D., Cheon S.H. Cytotoxic allyl retrochalcone from the roots of Glycyrrhiza inflata. Chem Pharm Bull (Tokyo) 2005, 53:694-695.
20. Fu Y., Hsieh T.C., Guo J., Kunicki J., Lee M.Y., Darzynkiewicz Z., et al. Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells. Biochem Biophys Res Commun 2004, 322:263-270.
21. Mi-Ichi F., Miyadera H., Kobayashi T., Takamiya S., Waki S., Iwata S., et al. Parasite mitochondria as a target of chemotherapy: inhibitory effect of licochalcone A on the Plasmodium falciparum respiratory chain. Ann NY Acad Sci 2005, 1056:46-54.
22. Zhai L., Blom J., Chen M., Christensen S.B., Kharazmi A. The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria. Antimicrob Agents Chemother 1995, 39:2742-2748.
23. Haraguchi H., Ishikawa H., Mizutani K., Tamura Y., Kinoshita T. Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg Med Chem 1998, 6:339-347.
24. Tsukiyama R., Katsura H., Tokuriki N., Kobayashi M. Antibacterial activity of licochalcone A against spore-forming bacteria. Antimicrob Agents Chemother 2002, 46:1226-1230.
25. Haraguchi H., Tanimoto K., Tamura Y., Mizutani K., Kinoshita T. Mode of antibacterial action of retrochalcones from Glycyrrhiza inflata. Phytochemistry 1998, 48:125-129.
26. Yoon G., Kang B.Y., Cheon S.H. Topoisomerase I inhibition and cytotoxicity of licochalcones A and E from Glycyrrhiza inflata. Arch Pharm Res 2007, 30:313-316.
27. Chang H.J., Yoon G., Park J.S., Kim M.H., Baek M.K., Kim N.H., et al. Induction of apoptosis by the licochalcone E in endothelial cells via modulation of NF-kappaB and Bcl-2 family. Biol Pharm Bull 2007, 30:2290-2293.
28. Ma X., Chow J.M., Gri G., Carra G., Gerosa F., Wolf S.F., et al. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med 1996, 183:147-157.
29. Fujii Y., Takeuchi H., Tanaka K., Sakuma S., Ohkubo Y., Mutoh S. Effects of FK506 (tacrolimus hydrate) on chronic oxazolone-induced dermatitis in rats. Eur J Pharmacol 2002, 456:115-121.
30. Fowler J.F., Hodge S.J., Tobin G.R. Persistent allergic contact dermatitis from squaric acid dibutyl ester. J Am Acad Dermatol 1993, 28:259-260.
31. Perrenoud D. Contact allergies due to drugs. Rev Méd Suisse Romande 1996, 116:221-227.
32. Vigan M. Contact dermatitis due to cosmetics. Ann Dermatol Vénéréol 2003, 130:467-471.
33. Hubler W.R., Hubler W.R. Dermatitis from a chromium dental plate. Contact Dermat 1983, 9:377-383.
34. Sharma A.D. Relationship between nickel allergy and diet. Indian J Dermatol Venereol Leprol 2007, 73:307-312.
35. Barker J.N. Psoriasis as a T cell-mediated autoimmune disease. Hosp Med 1998, 59:530-533.
36. Austin L.M., Ozawa M., Kikuchi T., Walters I.B., Krueger J.G. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 1999, 113:752-759.
37. Uyemura K., Yamamura M., Fivenson D.F., Modlin R.L., Nickoloff B.J. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993, 101:701-705.
38. Yawalkar N., Karlen S., Hunger R., Brand C.U., Braathen L.R. Expression of interleukin-12 is increased in psoriatic skin. J Invest Dermatol 1998, 111:1053-1057.
39. Lee E., Trepicchio W.L., Oestreicher J.L., Pittman D., Wang F., Chamian F., et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 2004, 199:125-130.
40. Chen X., Tan Z., Yue Q., Liu H., Liu Z., Li J. The expression of interleukin-23 (p19/p40) and inteleukin-12 (p35/p40) in psoriasis skin. J Huazhong Univ Sci Technol Med Sci 2006, 26:750-752.
41. Kauffman C.L., Aria N., Toichi E., McCormick T.S., Cooper K.D., Gottlieb A.B., et al. A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. J Invest Dermatol 2004, 123:1037-1044.
42. Krueger G.G., Langley R.G., Leonardi C., Yeilding N., Guzzo C., Wang Y., et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 2007, 356:580-592.
43. Nestle F.O., Conrad C. The IL-12 family member p40 chain as a master switch and novel therapeutic target in psoriasis. J Invest Dermatol 2004, 123. xiv-xv.
44. Truhlar S.M., Torpey J.W., Komives E.A. Regions of IkappaBalpha that are critical for its inhibition of NF-kappaB.DNA interaction fold upon binding to NF-kappaB. Proc Natl Acad Sci USA 2006, 103:18951-18956.
45. Beg A.A., Ruben S.M., Scheinman R.I., Haskill S., Rosen C.A., Baldwin A.S. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev 1992, 6:1899-1913.
46. Huxford T., Huang D.B., Malek S., Ghosh G. The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation. Cell 1998, 95:759-770.